Peter Sorger, PhD is the Otto Krayer Professor of Systems Biology at Harvard Medical School, Head of HiTS and Director of its Laboratory of Systems Pharmacology. Dr. Sorger’s research focuses on the systems biology of signal transduction networks controlling cell proliferation and death, the dysregulation of these networks in cancer and inflammatory diseases and the mechanisms of action of therapeutic drugs targeting signaling proteins, and he directs multi-disciplinary research in the LSP that uses mathematical and experimental approaches to develop and apply new concepts in drug discovery. Dr. Sorger received his AB from Harvard College, PhD from Trinity College, Cambridge University U.K., under the supervision of Hugh Pelham and trained as a postdoctoral fellow at the University of California, San Francisco with Harold Varmus and Andrew Murray. Prior to founding HiTS, Dr. Sorger served as a Professor of Biology and Biological Engineering at MIT and cofounded Merrimack Pharmaceuticals and Glencoe Software.